Survival after brain metastases from breast cancer in the trastuzumab era

Related Experiment Video

Updated: Aug 19, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

David G Kirsch, Carlos J Ledezma, Christina S Mathews

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |March 19, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
    05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    Related Experiment Videos

    Last Updated: Aug 19, 2026

    Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
    10:01

    Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

    Published on: August 2, 2022

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
    05:02

    Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

    Published on: February 4, 2021

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    Rewiring of Integrin Signaling and Cell-cycle Deregulation Drive SMARCB1-Deficient Epithelioid Sarcoma.

    bioRxiv : the preprint server for biology·2026

    Phase 1a Clinical Trial of XRD-0394, a First-in-Class Dual Ataxia-Telangiectasia Mutated and DNA-Dependent Protein Kinase Inhibitor, in Combination With Palliative Radiation Therapy.

    International journal of radiation oncology, biology, physics·2026

    Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas.

    Journal of the National Cancer Institute·2026

    A precision-constrained framework for evaluating noninvasive biomarkers in MASLD and beyond.

    Nature communications·2026

    Long-term real-world outcomes following preoperative radiotherapy and conservative surgery for trunk and extremity soft tissue sarcomas: a retrospective cohort study.

    EClinicalMedicine·2026

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non-Small Cell Lung Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Art as a Shared Space: Tracing the Unseen Through a Body Map.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us